Isoray (ISR) Stock: Circles Back Toward Leadership Position In Treating Prostate Cancer

By |April 25th, 2018|

If an investor pitched me on all of the positive features of IsoRay, Inc. (NYSEAMERICAN: ISR) and told me at the end of the presentation that the stock was selling for just 0.45 cents, I would ask him where I could back up the truck to load up on shares. After all, Isoray is […]